Update on regulation of GHRH and its actions on GH secretion in health and disease
- 21-01-2025
- Insulins
- Authors
- Antonio J. Montero-Hidalgo
- Mercedes del Rio-Moreno
- Jesús M. Pérez-Gómez
- Raúl M. Luque
- Rhonda D. Kineman
- Published in
- Reviews in Endocrine and Metabolic Disorders | Issue 3/2025
Abstract
This review focuses on our current understanding of how growth hormone releasing hormone (GHRH): 1) stimulates GH release and synthesis from pituitary growth hormone (GH)-producing cells (somatotropes), 2) drives somatotrope proliferation, 3) is negatively regulated by somatostatin (SST), GH and IGF1, 4) is altered throughout lifespan and in response to metabolic challenges, and 5) analogues can be used clinically to treat conditions of GH excess or deficiency. Although a large body of early work provides an underpinning for our current understanding of GHRH, this review specifically highlights more recent work that was made possible by state-of-the-art analytical tools, receptor-specific agonists and antagonists, high-resolution in vivo and ex vivo imaging and the development of tissue (cell) -specific ablation mouse models, to paint a more detailed picture of the regulation and actions of GHRH.
Advertisement
- Title
- Update on regulation of GHRH and its actions on GH secretion in health and disease
- Authors
-
Antonio J. Montero-Hidalgo
Mercedes del Rio-Moreno
Jesús M. Pérez-Gómez
Raúl M. Luque
Rhonda D. Kineman
- Publication date
- 21-01-2025
- Publisher
- Springer US
- Published in
-
Reviews in Endocrine and Metabolic Disorders / Issue 3/2025
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606 - DOI
- https://doi.org/10.1007/s11154-025-09943-y
This content is only visible if you are logged in and have the appropriate permissions.